Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy

Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac 123I- metaiodobenzylguanidine (123I-MIBG) scint...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2019, Vol.14 (6), p.e0217865-e0217865
Hauptverfasser: Chimura, Misato, Yamada, Shinichiro, Taniguchi, Yasuyo, Yasaka, Yoshinori, Kawai, Hiroya
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0217865
container_issue 6
container_start_page e0217865
container_title PloS one
container_volume 14
creator Chimura, Misato
Yamada, Shinichiro
Taniguchi, Yasuyo
Yasaka, Yoshinori
Kawai, Hiroya
description Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy which evaluates cardiac sympathetic nervous function, is a useful tool for predicting the prognosis in DCM. We investigated the predictive value of the combination of two different types of examinations, LGE on CMR and WR by 123I-MIBG scintigraphy for outcomes in DCM compared with LGE alone. One-hundred forty-eight DCM patients underwent CMR and 123I-MIBG scintigraphy. Patients were divided into 4 groups according to the presence or absence of LGE and WR cut-off value of 45% for predicting prognosis based on receiver operating characteristic curve analysis. Cardiac deaths, re-hospitalization for heart failure, implantation of a left ventricular assist device, and life-threatening ventricular arrhythmias were defined as clinical events. Forty-two DCM patients reached the clinical events during the median follow-up for 9.1 years (interquartile range, 8.0-9.2 years).Multivariable Cox regression analysis identified WR≥45%+LGE positive group as an independent predictor of cardiac events (HR 3.18, 95%CI 1.36-7.45, p = 0.008). Notably, there was no significance in the cardiac event-free survival rate between the WR
doi_str_mv 10.1371/journal.pone.0217865
format Article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_2244362266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6eb7662ef1d04351a732a2f98639376d</doaj_id><sourcerecordid>2244362266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3715-e6f1d853ff13b406eb6bc113890e7fdda55e9718082f9a8daedee4878a863bfd3</originalsourceid><addsrcrecordid>eNptUsuO1DAQjBCIXRb-AIElLlwy-JE4mQsSWvEYaSQucLY6difjkWMPdgIKP8hv4dmZXe0iTn5VV1W3qyheMrpiomHv9mGOHtzqEDyuKGdNK-tHxSVbC15KTsXje_uL4llKe0pr0Ur5tLgQjHPKKL0s_mxhQjKACc56O48E_Q68xhH9RIInGqKxoMkIg8fJahIxBX9EEB3Gzno05JeddoRxsSnJiBPYYEKH_vfihhm8NRlDkrZ-skOEw24haYrBD24hh4jG6ikRl8_lhHEk-mhDgyNhnrIAEuvJASab7aSTkLEuWzYnZ2FcQn7eLc-LJz24hC_O61Xx_dPHb9dfyu3Xz5vrD9tS55nVJcqembYWfc9EV1GJnew0Y6JdU2x6Y6Cucd2wlra8X0NrAA1i1TYttFJ0vRFXxesT78GFpM5_kBTnVSUk51JmxOaEMAH26hDtCHFRAay6uQhxUBDzJB2qLN9IyTF7opWoGTSCQxbOWmvRyKPa-7Pa3I1odJ5CBPeA9OGLtzs1hJ9K1keOJhO8PRPE8GPGNKnRJo3Ogccw3_iuZZ19rzP0zT_Q_3dXnVA6hpQi9ndmGFXHXN5WqWMu1TmXuezV_Ubuim6DKP4C9CrnfA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2244362266</pqid></control><display><type>article</type><title>Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy</title><source>Public Library of Science (PLoS) Journals Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Chimura, Misato ; Yamada, Shinichiro ; Taniguchi, Yasuyo ; Yasaka, Yoshinori ; Kawai, Hiroya</creator><creatorcontrib>Chimura, Misato ; Yamada, Shinichiro ; Taniguchi, Yasuyo ; Yasaka, Yoshinori ; Kawai, Hiroya</creatorcontrib><description>Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy which evaluates cardiac sympathetic nervous function, is a useful tool for predicting the prognosis in DCM. We investigated the predictive value of the combination of two different types of examinations, LGE on CMR and WR by 123I-MIBG scintigraphy for outcomes in DCM compared with LGE alone. One-hundred forty-eight DCM patients underwent CMR and 123I-MIBG scintigraphy. Patients were divided into 4 groups according to the presence or absence of LGE and WR cut-off value of 45% for predicting prognosis based on receiver operating characteristic curve analysis. Cardiac deaths, re-hospitalization for heart failure, implantation of a left ventricular assist device, and life-threatening ventricular arrhythmias were defined as clinical events. Forty-two DCM patients reached the clinical events during the median follow-up for 9.1 years (interquartile range, 8.0-9.2 years).Multivariable Cox regression analysis identified WR≥45%+LGE positive group as an independent predictor of cardiac events (HR 3.18, 95%CI 1.36-7.45, p = 0.008). Notably, there was no significance in the cardiac event-free survival rate between the WR&lt;45%+LGE positive and WR≥45%+LGE negative groups (p = 0.89). The combination of WR by 123I-MIBG scintigraphy and LGE on CMR, which evaluate different type of cardiac deterioration, serves as a stronger predictor of long-term outcomes in DCM patients than LGE alone.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0217865</identifier><identifier>PMID: 31220100</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>3-Iodobenzylguanidine - administration &amp; dosage ; Adult ; Aged ; Biology and Life Sciences ; Cardiomyopathy ; Cardiomyopathy, Dilated - diagnostic imaging ; Cardiomyopathy, Dilated - physiopathology ; Cohort Studies ; Congestive heart failure ; Contrast Media - administration &amp; dosage ; Dilated cardiomyopathy ; Failure analysis ; Female ; Fibrosis ; Gadolinium ; Gadolinium - administration &amp; dosage ; Growth factors ; Heart ; Heart diseases ; Heart failure ; Heart rate ; Humans ; Implantation ; Iodine ; Iodine Radioisotopes - administration &amp; dosage ; Magnetic resonance ; Magnetic Resonance Imaging - methods ; Male ; Medical prognosis ; Medicine and Health Sciences ; Middle Aged ; Patients ; Physical Sciences ; Prognosis ; Radionuclide Imaging ; Regression analysis ; Research and Analysis Methods ; Resonance ; Scintigraphy ; Survival Rate ; Systematic review ; Treatment Outcome ; Ventricle ; Washout</subject><ispartof>PloS one, 2019, Vol.14 (6), p.e0217865-e0217865</ispartof><rights>2019 Chimura et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019 Chimura et al 2019 Chimura et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3715-e6f1d853ff13b406eb6bc113890e7fdda55e9718082f9a8daedee4878a863bfd3</citedby><cites>FETCH-LOGICAL-c3715-e6f1d853ff13b406eb6bc113890e7fdda55e9718082f9a8daedee4878a863bfd3</cites><orcidid>0000-0003-3674-9171</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586397/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586397/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,4010,23845,27900,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31220100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chimura, Misato</creatorcontrib><creatorcontrib>Yamada, Shinichiro</creatorcontrib><creatorcontrib>Taniguchi, Yasuyo</creatorcontrib><creatorcontrib>Yasaka, Yoshinori</creatorcontrib><creatorcontrib>Kawai, Hiroya</creatorcontrib><title>Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy which evaluates cardiac sympathetic nervous function, is a useful tool for predicting the prognosis in DCM. We investigated the predictive value of the combination of two different types of examinations, LGE on CMR and WR by 123I-MIBG scintigraphy for outcomes in DCM compared with LGE alone. One-hundred forty-eight DCM patients underwent CMR and 123I-MIBG scintigraphy. Patients were divided into 4 groups according to the presence or absence of LGE and WR cut-off value of 45% for predicting prognosis based on receiver operating characteristic curve analysis. Cardiac deaths, re-hospitalization for heart failure, implantation of a left ventricular assist device, and life-threatening ventricular arrhythmias were defined as clinical events. Forty-two DCM patients reached the clinical events during the median follow-up for 9.1 years (interquartile range, 8.0-9.2 years).Multivariable Cox regression analysis identified WR≥45%+LGE positive group as an independent predictor of cardiac events (HR 3.18, 95%CI 1.36-7.45, p = 0.008). Notably, there was no significance in the cardiac event-free survival rate between the WR&lt;45%+LGE positive and WR≥45%+LGE negative groups (p = 0.89). The combination of WR by 123I-MIBG scintigraphy and LGE on CMR, which evaluate different type of cardiac deterioration, serves as a stronger predictor of long-term outcomes in DCM patients than LGE alone.</description><subject>3-Iodobenzylguanidine - administration &amp; dosage</subject><subject>Adult</subject><subject>Aged</subject><subject>Biology and Life Sciences</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - diagnostic imaging</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Cohort Studies</subject><subject>Congestive heart failure</subject><subject>Contrast Media - administration &amp; dosage</subject><subject>Dilated cardiomyopathy</subject><subject>Failure analysis</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Gadolinium</subject><subject>Gadolinium - administration &amp; dosage</subject><subject>Growth factors</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart failure</subject><subject>Heart rate</subject><subject>Humans</subject><subject>Implantation</subject><subject>Iodine</subject><subject>Iodine Radioisotopes - administration &amp; dosage</subject><subject>Magnetic resonance</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Middle Aged</subject><subject>Patients</subject><subject>Physical Sciences</subject><subject>Prognosis</subject><subject>Radionuclide Imaging</subject><subject>Regression analysis</subject><subject>Research and Analysis Methods</subject><subject>Resonance</subject><subject>Scintigraphy</subject><subject>Survival Rate</subject><subject>Systematic review</subject><subject>Treatment Outcome</subject><subject>Ventricle</subject><subject>Washout</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUsuO1DAQjBCIXRb-AIElLlwy-JE4mQsSWvEYaSQucLY6difjkWMPdgIKP8hv4dmZXe0iTn5VV1W3qyheMrpiomHv9mGOHtzqEDyuKGdNK-tHxSVbC15KTsXje_uL4llKe0pr0Ur5tLgQjHPKKL0s_mxhQjKACc56O48E_Q68xhH9RIInGqKxoMkIg8fJahIxBX9EEB3Gzno05JeddoRxsSnJiBPYYEKH_vfihhm8NRlDkrZ-skOEw24haYrBD24hh4jG6ikRl8_lhHEk-mhDgyNhnrIAEuvJASab7aSTkLEuWzYnZ2FcQn7eLc-LJz24hC_O61Xx_dPHb9dfyu3Xz5vrD9tS55nVJcqembYWfc9EV1GJnew0Y6JdU2x6Y6Cucd2wlra8X0NrAA1i1TYttFJ0vRFXxesT78GFpM5_kBTnVSUk51JmxOaEMAH26hDtCHFRAay6uQhxUBDzJB2qLN9IyTF7opWoGTSCQxbOWmvRyKPa-7Pa3I1odJ5CBPeA9OGLtzs1hJ9K1keOJhO8PRPE8GPGNKnRJo3Ogccw3_iuZZ19rzP0zT_Q_3dXnVA6hpQi9ndmGFXHXN5WqWMu1TmXuezV_Ubuim6DKP4C9CrnfA</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Chimura, Misato</creator><creator>Yamada, Shinichiro</creator><creator>Taniguchi, Yasuyo</creator><creator>Yasaka, Yoshinori</creator><creator>Kawai, Hiroya</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3674-9171</orcidid></search><sort><creationdate>2019</creationdate><title>Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy</title><author>Chimura, Misato ; Yamada, Shinichiro ; Taniguchi, Yasuyo ; Yasaka, Yoshinori ; Kawai, Hiroya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3715-e6f1d853ff13b406eb6bc113890e7fdda55e9718082f9a8daedee4878a863bfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>3-Iodobenzylguanidine - administration &amp; dosage</topic><topic>Adult</topic><topic>Aged</topic><topic>Biology and Life Sciences</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - diagnostic imaging</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Cohort Studies</topic><topic>Congestive heart failure</topic><topic>Contrast Media - administration &amp; dosage</topic><topic>Dilated cardiomyopathy</topic><topic>Failure analysis</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Gadolinium</topic><topic>Gadolinium - administration &amp; dosage</topic><topic>Growth factors</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart failure</topic><topic>Heart rate</topic><topic>Humans</topic><topic>Implantation</topic><topic>Iodine</topic><topic>Iodine Radioisotopes - administration &amp; dosage</topic><topic>Magnetic resonance</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Middle Aged</topic><topic>Patients</topic><topic>Physical Sciences</topic><topic>Prognosis</topic><topic>Radionuclide Imaging</topic><topic>Regression analysis</topic><topic>Research and Analysis Methods</topic><topic>Resonance</topic><topic>Scintigraphy</topic><topic>Survival Rate</topic><topic>Systematic review</topic><topic>Treatment Outcome</topic><topic>Ventricle</topic><topic>Washout</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chimura, Misato</creatorcontrib><creatorcontrib>Yamada, Shinichiro</creatorcontrib><creatorcontrib>Taniguchi, Yasuyo</creatorcontrib><creatorcontrib>Yasaka, Yoshinori</creatorcontrib><creatorcontrib>Kawai, Hiroya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chimura, Misato</au><au>Yamada, Shinichiro</au><au>Taniguchi, Yasuyo</au><au>Yasaka, Yoshinori</au><au>Kawai, Hiroya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2019</date><risdate>2019</risdate><volume>14</volume><issue>6</issue><spage>e0217865</spage><epage>e0217865</epage><pages>e0217865-e0217865</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) is limited in its ability to detect diffuse interstitial fibrosis, which is commonly found in idiopathic dilated cardiomyopathy (DCM). On the other hand, Washout rate (WR) by cardiac 123I- metaiodobenzylguanidine (123I-MIBG) scintigraphy which evaluates cardiac sympathetic nervous function, is a useful tool for predicting the prognosis in DCM. We investigated the predictive value of the combination of two different types of examinations, LGE on CMR and WR by 123I-MIBG scintigraphy for outcomes in DCM compared with LGE alone. One-hundred forty-eight DCM patients underwent CMR and 123I-MIBG scintigraphy. Patients were divided into 4 groups according to the presence or absence of LGE and WR cut-off value of 45% for predicting prognosis based on receiver operating characteristic curve analysis. Cardiac deaths, re-hospitalization for heart failure, implantation of a left ventricular assist device, and life-threatening ventricular arrhythmias were defined as clinical events. Forty-two DCM patients reached the clinical events during the median follow-up for 9.1 years (interquartile range, 8.0-9.2 years).Multivariable Cox regression analysis identified WR≥45%+LGE positive group as an independent predictor of cardiac events (HR 3.18, 95%CI 1.36-7.45, p = 0.008). Notably, there was no significance in the cardiac event-free survival rate between the WR&lt;45%+LGE positive and WR≥45%+LGE negative groups (p = 0.89). The combination of WR by 123I-MIBG scintigraphy and LGE on CMR, which evaluate different type of cardiac deterioration, serves as a stronger predictor of long-term outcomes in DCM patients than LGE alone.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>31220100</pmid><doi>10.1371/journal.pone.0217865</doi><orcidid>https://orcid.org/0000-0003-3674-9171</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2019, Vol.14 (6), p.e0217865-e0217865
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2244362266
source Public Library of Science (PLoS) Journals Open Access; MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects 3-Iodobenzylguanidine - administration & dosage
Adult
Aged
Biology and Life Sciences
Cardiomyopathy
Cardiomyopathy, Dilated - diagnostic imaging
Cardiomyopathy, Dilated - physiopathology
Cohort Studies
Congestive heart failure
Contrast Media - administration & dosage
Dilated cardiomyopathy
Failure analysis
Female
Fibrosis
Gadolinium
Gadolinium - administration & dosage
Growth factors
Heart
Heart diseases
Heart failure
Heart rate
Humans
Implantation
Iodine
Iodine Radioisotopes - administration & dosage
Magnetic resonance
Magnetic Resonance Imaging - methods
Male
Medical prognosis
Medicine and Health Sciences
Middle Aged
Patients
Physical Sciences
Prognosis
Radionuclide Imaging
Regression analysis
Research and Analysis Methods
Resonance
Scintigraphy
Survival Rate
Systematic review
Treatment Outcome
Ventricle
Washout
title Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Late%20gadolinium%20enhancement%20on%20cardiac%20magnetic%20resonance%20combined%20with%20123I-%20metaiodobenzylguanidine%20scintigraphy%20strongly%20predicts%20long-term%20clinical%20outcome%20in%20patients%20with%20dilated%20cardiomyopathy&rft.jtitle=PloS%20one&rft.au=Chimura,%20Misato&rft.date=2019&rft.volume=14&rft.issue=6&rft.spage=e0217865&rft.epage=e0217865&rft.pages=e0217865-e0217865&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0217865&rft_dat=%3Cproquest_plos_%3E2244362266%3C/proquest_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2244362266&rft_id=info:pmid/31220100&rft_doaj_id=oai_doaj_org_article_6eb7662ef1d04351a732a2f98639376d&rfr_iscdi=true